Posted On: July 18, 2023

Stock Report : HIKAL (NSE) 17 Jul 2023

Outlook: Bearish 

Sector: Healthcare  

Industry: Drug Manufactures 

Hikal Limited is an Indian multinational company specializing in custom development and manufacturing of intermediates, active pharmaceutical ingredients (APIs), and specialty chemicals. The company has a significant presence in the pharmaceutical and agrochemical industries, offering a range of products and services to global customers. 

#xCalData predicts that # HIKAL will continue its bearish phase over the next five days and trend within the range of 295 to 309. 

In comparison to the previous month, the price of the stock has experienced a decline of 4.83% indicating a bearish.

The Stock has doubled thrice since 07 Sep 2015 and took an average of 2.0 years to double.

The stock has not shown seasonality trend in the past. 

Reviewing the returns for the past 5 years for the same week, we see the stock has given negative returns in 2 years in the past. 

Majority of the technical ratios trend towards Bearish side of the spectrum. Only some of the technical indicators namely ASI indicate Bullish view. 

Collectively, xCalData suggests the stock would be in Bearish zone for next 5 days. 

#xCalData is an exceptional app available for Android devices that offers unbiased insights into stocks, allowing investors to make informed decisions. With its user-friendly interface and comprehensive features, xCalData provides a valuable resource for anyone interested in the stock market.  Download the app from google play. 

For Actionable Intelligence, subscribe to xCalData app on Android devices: https://tinyurl.com/downloadxCalData.

Banner ads

Popular Posts

Popular Categories

Similar Posts

.August 23, 2024

#GLAND (NSE) Stock Report | 22 Nov 2024

.August 23, 2024

#STERTOOLS (NSE) Stock Report | 21 Nov 2024

.August 23, 2024

#SAKAR (NSE) Stock Report | 19 Nov 2024

.August 23, 2024

#EVEREADY (NSE) Stock Report | 19 Nov 2024